Identification of a long noncoding RNA Gm17501 as a novel negative regulator of cardiac hypertrophy.
Identification of a long noncoding RNA Gm17501 as a novel negative regulator of cardiac hypertrophy.
复制标题
DOI:
10.1016/j.yexcr.2022.113262
复制
发表时间:
2022-06
影响因子:
3.7
通讯作者:
Zhuomin Liang;Wendong Fan;Hao Chen;Zhan-Peng Huang;R. Fang;Bin Dong;Chen Chen-Chen;Jiayong Li;
中科院分区:
文献类型:
--
作者:
Zhuomin Liang;Wendong Fan;Hao Chen;Zhan-Peng Huang;R. Fang;Bin Dong;Chen Chen-Chen;Jiayong Li;
Pathological cardiac hypertrophy is an independent risk factor for the development of heart failure. Long noncoding RNAs (lncRNAs), an emerging class of non-protein-coding transcripts, are involved in regulation of multiple cardiac diseases through diverse molecular mechanism, whereas the role of cytoplasmic lncRNAs in regulating cardiac hypertrophy remains unclear. In this study, we identified a novel and functional long noncoding RNA Gm17501, which was predominantly expressed in the cytoplasm of cardiomyocytes. The expression level of lncRNA Gm17501 was altered in cardiac hypertrophy induced by pressure overload and phenylephrine treatment. Moreover, lncRNA Gm17501 expression was decreased in the heart tissue of patients with heart failure. Silencing lncRNA Gm17501 aggravated cardiac hypertrophy under pathological stress. Inhibition of lncRNA Gm17501 did not alter the expression of nearby genes but decreased mRNA level of calcium handling proteins which were involved in cardiac contraction. Therefore, the cytoplasmic lncRNA Gm17501 might protect cardiomyocytes against hypertrophy, possibly by maintaining calcium signaling pathway.